CCR Translation for This Article from A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

MLA

John M. Kirkwood, et al. CCR Translation for This Article from A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602). Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95fe8e35993b985fd73187e46515a1e6&authtype=sso&custid=ns315887.

APA

John M. Kirkwood, Philip D. Leming, Theresa L. Whiteside, Lisa H. Butterfield, Walter C. Olson, Kimberly A. Chianese-Bullock, Fengmin Zhao, Sandra Lee, & Craig L. Slingluff. (2023). CCR Translation for This Article from A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602).

Chicago

John M. Kirkwood, Philip D. Leming, Theresa L. Whiteside, Lisa H. Butterfield, Walter C. Olson, Kimberly A. Chianese-Bullock, Fengmin Zhao, Sandra Lee, and Craig L. Slingluff. 2023. “CCR Translation for This Article from A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602),” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95fe8e35993b985fd73187e46515a1e6&authtype=sso&custid=ns315887.